168 related articles for article (PubMed ID: 27274980)
1. Clinical epidemiology of vancomycin-resistant
Britt NS; Potter EM
J Glob Antimicrob Resist; 2016 Jun; 5():57-61. PubMed ID: 27274980
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the Effectiveness and Safety of Linezolid and Daptomycin in Vancomycin-Resistant Enterococcal Bloodstream Infection: A National Cohort Study of Veterans Affairs Patients.
Britt NS; Potter EM; Patel N; Steed ME
Clin Infect Dis; 2015 Sep; 61(6):871-8. PubMed ID: 26063715
[TBL] [Abstract][Full Text] [Related]
3. Clinical management of non-faecium non-faecalis vancomycin-resistant enterococci infection. Focus on Enterococcus gallinarum and Enterococcus casseliflavus/flavescens.
Monticelli J; Knezevich A; Luzzati R; Di Bella S
J Infect Chemother; 2018 Apr; 24(4):237-246. PubMed ID: 29396199
[TBL] [Abstract][Full Text] [Related]
4. Vancomycin-resistant Enterococcal Bloodstream Infections in Hematopoietic Stem Cell Transplant Recipients and Patients with Hematologic Malignancies: Impact of Daptomycin MICs of 3 to 4 mg/L.
Chong PP; van Duin D; Bangdiwala A; Ivanova A; Miller WC; Weber DJ; Gilligan PH; Shea TC
Clin Ther; 2016 Nov; 38(11):2468-2476. PubMed ID: 27771176
[TBL] [Abstract][Full Text] [Related]
5. Comparative Effectiveness and Safety of Standard-, Medium-, and High-Dose Daptomycin Strategies for the Treatment of Vancomycin-Resistant Enterococcal Bacteremia Among Veterans Affairs Patients.
Britt NS; Potter EM; Patel N; Steed ME
Clin Infect Dis; 2017 Mar; 64(5):605-613. PubMed ID: 28011602
[TBL] [Abstract][Full Text] [Related]
6. Emergence of vancomycin-resistant Enterococcus bloodstream infections in southern Taiwan.
Chou CH; Lee NY; Lee HC; Chang CM; Lee CC; Ko WC
J Microbiol Immunol Infect; 2012 Jun; 45(3):221-7. PubMed ID: 22578639
[TBL] [Abstract][Full Text] [Related]
7. Daptomycin versus linezolid for the treatment of vancomycin-resistant enterococcal bacteraemia: implications of daptomycin dose.
Chuang YC; Lin HY; Chen PY; Lin CY; Wang JT; Chang SC
Clin Microbiol Infect; 2016 Oct; 22(10):890.e1-890.e7. PubMed ID: 27475738
[TBL] [Abstract][Full Text] [Related]
8. Systemic inflammatory response syndrome in adult patients with nosocomial bloodstream infections due to enterococci.
Bar K; Wisplinghoff H; Wenzel RP; Bearman GM; Edmond MB
BMC Infect Dis; 2006 Sep; 6():145. PubMed ID: 17002792
[TBL] [Abstract][Full Text] [Related]
9. A retrospective clinical comparison of daptomycin vs daptomycin and a beta-lactam antibiotic for treating vancomycin-resistant Enterococcus faecium bloodstream infections.
Chuang YC; Chen PY; Lin CY; Chen YC; Wang JT; Chang SC
Sci Rep; 2018 Jan; 8(1):1632. PubMed ID: 29374204
[TBL] [Abstract][Full Text] [Related]
10. Effect of Daptomycin Dose on the Outcome of Vancomycin-Resistant, Daptomycin-Susceptible Enterococcus faecium Bacteremia.
Chuang YC; Lin HY; Chen PY; Lin CY; Wang JT; Chen YC; Chang SC
Clin Infect Dis; 2017 Apr; 64(8):1026-1034. PubMed ID: 28329222
[TBL] [Abstract][Full Text] [Related]
11. A 10-year profile of enterococcal bloodstream infections at a tertiary-care hospital in Japan.
Suzuki H; Hase R; Otsuka Y; Hosokawa N
J Infect Chemother; 2017 Jun; 23(6):390-393. PubMed ID: 28385565
[TBL] [Abstract][Full Text] [Related]
12. Effect of Continuous and Sequential Therapy among Veterans Receiving Daptomycin or Linezolid for Vancomycin-Resistant Enterococcus faecium Bacteremia.
Britt NS; Potter EM; Patel N; Steed ME
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28264856
[TBL] [Abstract][Full Text] [Related]
13. Similar efficacy and safety of daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bloodstream infections: a meta-analysis.
Zhao M; Liang L; Ji L; Chen D; Zhang Y; Zhu Y; Patel K
Int J Antimicrob Agents; 2016 Sep; 48(3):231-8. PubMed ID: 27475877
[TBL] [Abstract][Full Text] [Related]
14. Comparison of linezolid and daptomycin for the treatment of vancomycin-resistant enterococcal bacteremia.
Narayanan N; Rai R; Vaidya P; Desai A; Bhowmick T; Weinstein MP
Ther Adv Infect Dis; 2019; 6():2049936119828964. PubMed ID: 30792858
[TBL] [Abstract][Full Text] [Related]
15. Systematic review and meta-analysis of linezolid and daptomycin for treatment of vancomycin-resistant enterococcal bloodstream infections.
Whang DW; Miller LG; Partain NM; McKinnell JA
Antimicrob Agents Chemother; 2013 Oct; 57(10):5013-8. PubMed ID: 23896468
[TBL] [Abstract][Full Text] [Related]
16. Bloodstream infections caused by Enterococcus spp: A 10-year retrospective analysis at a tertiary hospital in China.
Zheng JX; Li H; Pu ZY; Wang HY; Deng XB; Liu XJ; Deng QW; Yu ZJ
J Huazhong Univ Sci Technolog Med Sci; 2017 Apr; 37(2):257-263. PubMed ID: 28397040
[TBL] [Abstract][Full Text] [Related]
17. Influence of daptomycin dose and fosfomycin susceptibility on outcome of vancomycin-resistant Enterococcus faecium bloodstream infections treated with daptomycin and fosfomycin combination.
Chuang YC; Tseng TC; Wang JT; Lin CY; Huang SH; Chen YC; Chang SC
J Antimicrob Chemother; 2022 Apr; 77(5):1436-1443. PubMed ID: 35141753
[TBL] [Abstract][Full Text] [Related]
18. Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis.
Chou YY; Lin TY; Lin JC; Wang NC; Peng MY; Chang FY
J Microbiol Immunol Infect; 2008 Apr; 41(2):124-9. PubMed ID: 18473099
[TBL] [Abstract][Full Text] [Related]
19. Disposition of linezolid or daptomycin in Enterococcal bloodstream infections according to vancomycin resistant Enterococcus colonization.
Short E; Esterly J; Postelnick M; Ong J; McLaughlin M
Antimicrob Resist Infect Control; 2014; 3(1):37. PubMed ID: 25671098
[TBL] [Abstract][Full Text] [Related]
20. Optimizing therapy for vancomycin-resistant enterococcal bacteremia in children.
Tamma PD; Hsu AJ
Curr Opin Infect Dis; 2014 Dec; 27(6):517-27. PubMed ID: 25313503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
